DeuterOncology

Biotech · Liège, BE

Clinical-stage developer of MET kinase inhibitors for lung cancer.

In the network

Shares the most investors with (number = shared investors):

Create a free EquityFlow account to see DeuterOncology's 1 funding round, 3 investors, 12 similar companies.